4//SEC Filing
Leonard Reid 4
Accession 0000899243-22-000510
CIK 0001785530other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 4:26 PM ET
Size
7.8 KB
Accession
0000899243-22-000510
Insider Transaction Report
Form 4
Leonard Reid
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2021-12-30$1.56/sh+14,102$21,999→ 14,102 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-12-30−14,102→ 47,034 totalExercise: $1.56Exp: 2030-05-19→ Common Stock (14,102 underlying)
Holdings
- 122,157(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]The option was granted on May 20, 2020 with a Vesting Commencement Date of June 1, 2020. The shares underlying the option vest over four years, with 25% of the shares vesting on the first anniversary of the Vesting Commencement Date and 2.0833% of the shares vesting each month thereafter through June 1, 2024.
Documents
Issuer
Werewolf Therapeutics, Inc.
CIK 0001785530
Entity typeother
Related Parties
1- filerCIK 0001857795
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 4:26 PM ET
- Size
- 7.8 KB